Tirzepatide, a GLP-1/GIP receptor agonist, not only facilitates significant weight loss, but also appears to promote the bodys own testosterone production
BMC medical research methodology 5, 13 (2005)
pH: pH 5.0-7.0 4
In fact, the FDA designated BPC-157 as a Category 2 bulk drug substance, meaning it cannot be compounded by commercial pharmaceutical companies due to insufficient safety evidence in humans
Food and Drug Administration , 2022, Amisi, C
60 mg Other ingredients: hypo-allergenic plant fiber (cellulose), vegetarian capsule (cellulose, water)